Your browser doesn't support javascript.
loading
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy.
Liu, Xin; Xu, Yixiang; Xiong, Wei; Yin, Bingnan; Huang, Yuqian; Chu, Junjun; Xing, Changsheng; Qian, Chen; Du, Yang; Duan, Tianhao; Wang, Helen Y; Zhang, Ningyan; Yu, John S; An, Zhiqiang; Wang, Rongfu.
Afiliação
  • Liu X; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Xu Y; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
  • Xiong W; Institute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, Texas, USA.
  • Yin B; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Huang Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Chu J; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Xing C; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
  • Qian C; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
  • Du Y; Xiangya School of Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • Duan T; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Wang HY; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
  • Zhang N; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Yu JS; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
  • An Z; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Wang R; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA.
J Immunother Cancer ; 10(3)2022 03.
Article em En | MEDLINE | ID: mdl-35338087
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Receptores de Antígenos Quiméricos / Melanoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Receptores de Antígenos Quiméricos / Melanoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article